(Q34554248)

English

Individualised cancer chemotherapy: strategies and performance of prospective studies on therapeutic drug monitoring with dose adaptation: a review

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

Individualised cancer chemotherapy: strategies and performance of prospective studies on therapeutic drug monitoring with dose adaptation: a review (English)

1 reference

Europe PubMed Central

3 August 2017

1 reference

based on heuristic

inferred from title

5

object named as

Jos H Beijnen

1 reference

Europe PubMed Central

3 August 2017

author name string

Milly E de Jonge

1

1 reference

Europe PubMed Central

3 August 2017

Alwin D R Huitema

2

1 reference

Europe PubMed Central

3 August 2017

Jan H M Schellens

3

1 reference

Europe PubMed Central

3 August 2017

Sjoerd Rodenhuis

4

1 reference

Europe PubMed Central

3 August 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

3 August 2017

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

3 August 2017

44

1 reference

Europe PubMed Central

3 August 2017

147-173

1 reference

Europe PubMed Central

3 August 2017

2

1 reference

Europe PubMed Central

3 August 2017

https://scigraph.springernature.com/pub.10.2165/00003088-200544020-00002

0 references

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methodological issues in pharmacokinetic-pharmacodynamic modelling.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic optimisation of cancer chemotherapy. Effect on outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reappraisal of some dosage adjustment guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetically guided administration of chemotherapeutic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Bayesian dosing method for carboplatin given by continuous infusion for 120 h.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic monitoring of continuous infusion etoposide in small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacologically based dosing of etoposide: a means of safely increasing dose intensity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limited-sampling models for anticancer agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetics of etoposide: application to therapeutic drug monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring of 21-day oral etoposide in patients with advanced non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer genetics and their application to individualised medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patient characteristics associated with high-risk methotrexate concentrations and toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I pharmacokinetic study of multicycle high-dose carboplatin followed by peripheral-blood stem-cell infusion in patients with cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escalating teniposide systemic exposure to increase dose intensity for pediatric cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Escalating systemic exposure of continuous infusion topotecan in children with recurrent acute leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring opportunities in cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised, concentration-controlled, comparison of standard (5-day) vs. prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individual dose adaptation of anticancer drugs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of busulfan area under the curve with veno-occlusive disease following BMT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics in cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring in cancer management.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adaptive control of etoposide administration: impact of interpatient pharmacodynamic variability.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Individualization of the dosage of high-dose methotrexate by assaying plasma concentration. Therapeutic value in osteogenic sarcoma]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics-pharmacodynamics of anticancer drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A general model for time-dissociated pharmacokinetic-pharmacodynamic relationship exemplified by paclitaxel myelosuppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring of etoposide in a 14-day infusion for non-small-cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individual adaptive dosing of topotecan in ovarian cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Feedback control methods for drug dosage optimisation. Concepts, classification and clinical application

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical randomized study of 5FU monitoring versus standard dose in patients with head and neck cancer: preliminary results.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concentration-controlled or effect-controlled trials: useful alternatives to conventional dose-controlled trials?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring of cytotoxic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adaptive intrapatient dose escalation of cisplatin in patients with advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adaptive control methods for the dose individualisation of anticancer agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma concentration monitoring of busulfan: does it improve clinical outcome?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic optimisation of anticancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revisiting some factors contributing to variability

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Making TDM work to optimize cancer chemotherapy: a multidisciplinary team approach.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of high-dose methotrexate in adult osteogenic sarcoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetically guided dosing for intravenous melphalan: a pilot study in patients with advanced ovarian adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationales for a pharmacologically optimized treatment of acute nonlymphocytic leukemia with cytosine arabinoside.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of carboplatin clearance from standard morphological and biological patient characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adaptive control with feedback of suramin using intermittent infusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose monitoring of 5-fluorouracil in patients with colorectal or head and neck cancer--status of the art.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosage adjustment of high-dose methotrexate using Bayesian estimation: a comparative study of two different concentrations at the end of 8-h infusions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hexamethylene bisacetamide in myelodysplastic syndrome: effect of five-day exposure to maximal therapeutic concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individual 5FU-dose adaptation schedule using bimonthly pharmacokinetically modulated LV5FU2 regimen: a feasibility study in patients with advanced colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacologically directed ara-C therapy for refractory leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expanding clinical applications of population pharmacodynamic modelling

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualizing dosing of cancer chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practical treatment guide for dose individualisation in cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Approaches to optimal dosing of hexamethylene bisacetamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Pharmacokinetic monitoring with dosage adjustment of 5 fluorouracil administered by continuous infusion]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic drug monitoring in 21-day oral etoposide treatment for lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15656695

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003088-200544020-00002

1 reference

Europe PubMed Central

3 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34554248&oldid=1949999215"